Enhancement of radiation sensitivity in lung cancer cells by celastrol is mediated by inhibition of Hsp90

Ji Hyun Lee, Kyu Jin Choi, Woo Duck Seo, Soon Young Jang, Mira Kim, Byong Won Lee, Jun Young Kim, Seong Man Kang, Ki Hun Park, Yun Sil Lee, Sangwoo Bae

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

The radiosensitizing activity of celastrol, a quinone methide triterpene was examined. We found that celastrol treatment of the NCI-H460 lung cancer cell line increased radiation-induced cell killing. The increased radiosensitivity was correlated with decreased levels of Hsp90 clients, such as EGFR, ErbB2 and survivin as well as with increased p53 expression. Celastrol inhibited the ATP-binding activity of Hsp90. Furthermore, celastrol treatment dissociated an Hsp90 client protein, EGFR, and this in turn resulted in degradation of the client protein. These results were not observed with another structurally similar triterpenoid, 6β-acetonyl-22β-hydroxytingenol (TG), suggesting that a specific structural feature of the triterpenoid is required for radiosensitization. Moreover celastrol treatment increased p53 levels by phosphorylating Ser15 and Ser20 residues as well as by inhibiting its proteasomal degradation. Celastrol may be considered an effective radiosensitizer acting as an inhibitor of Hsp90 and a p53 activator. The two activities could be applicable to a broad range of cancer cells with either wild-type or mutant p53 because either activity could be effective for the enhancement of radiation cell killing. Further analysis with other triterpenoids should identify the functional moiety of the structure and additional candidates for effective radiosensitizers, which can be used in combined radiotherapy.

Original languageEnglish
Pages (from-to)441-446
Number of pages6
JournalInternational Journal of Molecular Medicine
Volume27
Issue number3
DOIs
Publication statusPublished - 2011 Mar 1

Fingerprint

Radiation Tolerance
Lung Neoplasms
Radiation
Triterpenes
Proteolysis
tripterine
Radiotherapy
Therapeutics
Adenosine Triphosphate
Cell Line
Neoplasms
Proteins

Keywords

  • Celastrol
  • Client proteins
  • Hsp90
  • p53
  • Radiation sensitivity

ASJC Scopus subject areas

  • Genetics

Cite this

Enhancement of radiation sensitivity in lung cancer cells by celastrol is mediated by inhibition of Hsp90. / Lee, Ji Hyun; Choi, Kyu Jin; Seo, Woo Duck; Jang, Soon Young; Kim, Mira; Lee, Byong Won; Kim, Jun Young; Kang, Seong Man; Park, Ki Hun; Lee, Yun Sil; Bae, Sangwoo.

In: International Journal of Molecular Medicine, Vol. 27, No. 3, 01.03.2011, p. 441-446.

Research output: Contribution to journalArticle

Lee, JH, Choi, KJ, Seo, WD, Jang, SY, Kim, M, Lee, BW, Kim, JY, Kang, SM, Park, KH, Lee, YS & Bae, S 2011, 'Enhancement of radiation sensitivity in lung cancer cells by celastrol is mediated by inhibition of Hsp90', International Journal of Molecular Medicine, vol. 27, no. 3, pp. 441-446. https://doi.org/10.3892/ijmm.2011.601
Lee, Ji Hyun ; Choi, Kyu Jin ; Seo, Woo Duck ; Jang, Soon Young ; Kim, Mira ; Lee, Byong Won ; Kim, Jun Young ; Kang, Seong Man ; Park, Ki Hun ; Lee, Yun Sil ; Bae, Sangwoo. / Enhancement of radiation sensitivity in lung cancer cells by celastrol is mediated by inhibition of Hsp90. In: International Journal of Molecular Medicine. 2011 ; Vol. 27, No. 3. pp. 441-446.
@article{109aabaf5e604347bf47f73025861870,
title = "Enhancement of radiation sensitivity in lung cancer cells by celastrol is mediated by inhibition of Hsp90",
abstract = "The radiosensitizing activity of celastrol, a quinone methide triterpene was examined. We found that celastrol treatment of the NCI-H460 lung cancer cell line increased radiation-induced cell killing. The increased radiosensitivity was correlated with decreased levels of Hsp90 clients, such as EGFR, ErbB2 and survivin as well as with increased p53 expression. Celastrol inhibited the ATP-binding activity of Hsp90. Furthermore, celastrol treatment dissociated an Hsp90 client protein, EGFR, and this in turn resulted in degradation of the client protein. These results were not observed with another structurally similar triterpenoid, 6β-acetonyl-22β-hydroxytingenol (TG), suggesting that a specific structural feature of the triterpenoid is required for radiosensitization. Moreover celastrol treatment increased p53 levels by phosphorylating Ser15 and Ser20 residues as well as by inhibiting its proteasomal degradation. Celastrol may be considered an effective radiosensitizer acting as an inhibitor of Hsp90 and a p53 activator. The two activities could be applicable to a broad range of cancer cells with either wild-type or mutant p53 because either activity could be effective for the enhancement of radiation cell killing. Further analysis with other triterpenoids should identify the functional moiety of the structure and additional candidates for effective radiosensitizers, which can be used in combined radiotherapy.",
keywords = "Celastrol, Client proteins, Hsp90, p53, Radiation sensitivity",
author = "Lee, {Ji Hyun} and Choi, {Kyu Jin} and Seo, {Woo Duck} and Jang, {Soon Young} and Mira Kim and Lee, {Byong Won} and Kim, {Jun Young} and Kang, {Seong Man} and Park, {Ki Hun} and Lee, {Yun Sil} and Sangwoo Bae",
year = "2011",
month = "3",
day = "1",
doi = "10.3892/ijmm.2011.601",
language = "English",
volume = "27",
pages = "441--446",
journal = "International Journal of Molecular Medicine",
issn = "1107-3756",
publisher = "Spandidos Publications",
number = "3",

}

TY - JOUR

T1 - Enhancement of radiation sensitivity in lung cancer cells by celastrol is mediated by inhibition of Hsp90

AU - Lee, Ji Hyun

AU - Choi, Kyu Jin

AU - Seo, Woo Duck

AU - Jang, Soon Young

AU - Kim, Mira

AU - Lee, Byong Won

AU - Kim, Jun Young

AU - Kang, Seong Man

AU - Park, Ki Hun

AU - Lee, Yun Sil

AU - Bae, Sangwoo

PY - 2011/3/1

Y1 - 2011/3/1

N2 - The radiosensitizing activity of celastrol, a quinone methide triterpene was examined. We found that celastrol treatment of the NCI-H460 lung cancer cell line increased radiation-induced cell killing. The increased radiosensitivity was correlated with decreased levels of Hsp90 clients, such as EGFR, ErbB2 and survivin as well as with increased p53 expression. Celastrol inhibited the ATP-binding activity of Hsp90. Furthermore, celastrol treatment dissociated an Hsp90 client protein, EGFR, and this in turn resulted in degradation of the client protein. These results were not observed with another structurally similar triterpenoid, 6β-acetonyl-22β-hydroxytingenol (TG), suggesting that a specific structural feature of the triterpenoid is required for radiosensitization. Moreover celastrol treatment increased p53 levels by phosphorylating Ser15 and Ser20 residues as well as by inhibiting its proteasomal degradation. Celastrol may be considered an effective radiosensitizer acting as an inhibitor of Hsp90 and a p53 activator. The two activities could be applicable to a broad range of cancer cells with either wild-type or mutant p53 because either activity could be effective for the enhancement of radiation cell killing. Further analysis with other triterpenoids should identify the functional moiety of the structure and additional candidates for effective radiosensitizers, which can be used in combined radiotherapy.

AB - The radiosensitizing activity of celastrol, a quinone methide triterpene was examined. We found that celastrol treatment of the NCI-H460 lung cancer cell line increased radiation-induced cell killing. The increased radiosensitivity was correlated with decreased levels of Hsp90 clients, such as EGFR, ErbB2 and survivin as well as with increased p53 expression. Celastrol inhibited the ATP-binding activity of Hsp90. Furthermore, celastrol treatment dissociated an Hsp90 client protein, EGFR, and this in turn resulted in degradation of the client protein. These results were not observed with another structurally similar triterpenoid, 6β-acetonyl-22β-hydroxytingenol (TG), suggesting that a specific structural feature of the triterpenoid is required for radiosensitization. Moreover celastrol treatment increased p53 levels by phosphorylating Ser15 and Ser20 residues as well as by inhibiting its proteasomal degradation. Celastrol may be considered an effective radiosensitizer acting as an inhibitor of Hsp90 and a p53 activator. The two activities could be applicable to a broad range of cancer cells with either wild-type or mutant p53 because either activity could be effective for the enhancement of radiation cell killing. Further analysis with other triterpenoids should identify the functional moiety of the structure and additional candidates for effective radiosensitizers, which can be used in combined radiotherapy.

KW - Celastrol

KW - Client proteins

KW - Hsp90

KW - p53

KW - Radiation sensitivity

UR - http://www.scopus.com/inward/record.url?scp=79551598917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79551598917&partnerID=8YFLogxK

U2 - 10.3892/ijmm.2011.601

DO - 10.3892/ijmm.2011.601

M3 - Article

C2 - 21249311

AN - SCOPUS:79551598917

VL - 27

SP - 441

EP - 446

JO - International Journal of Molecular Medicine

JF - International Journal of Molecular Medicine

SN - 1107-3756

IS - 3

ER -